About DSpace Software

Digital Knowledge Repository of Central Drug Research Institute, Lucknow (India) >
Publications of CDRI Scientists >
Microbiology >

Please use this identifier to cite or link to this item: http://hdl.handle.net/123456789/505

Title: Comparison of the Effect of Compound CDRI 80/53 [N-(3-acetyl-4,5-dihydro-2-furanyl)-N4-(6 -methoxy-8-quinolinyl)1,4- pentanediamine] with Primaquine on Human Erythrocytes In Vitro
Authors: Anklesaria, P S
Ashar, V J
Kshirsagar, N A
Gupta, K C
Issue Date: 1994
Citation: Tropical diseases: molecular biology & control strategies,1994,256-261
Abstract: Comparative in vitro study of a malaria antirelapse compound CDRI Code 80/53 with primaquine (PQ) was done on the erythrocytes of eight normal and six G-6-PD-deficient individuals. Reduced glutathione (GSH) was estimated in the RBCs exposed to the in vitro action of the drugs. Statistically significant decreases were observed at 25 ug/ml and 50 ยต/ml doses of PQ as compared t the equivalent doses of compound 80/53 in both normal and G-6-PD-deficient erythrocytes. The study showed that compound CDRI 80/53 did not damage normal as well as G-6-PD-deficient erythrocytes to the same extent as PQ.
URI: http://hdl.handle.net/123456789/505
Appears in Collections:Microbiology

Files in This Item:

File Description SizeFormat
book-tropical diseases molecular biology & control stategies-1994-286.pdf1350KbAdobe PDFView/Open

All items in DSpace are protected by copyright, with all rights reserved.

 

DKR - A Collaborative Effort of Documentation & Library Services Division and Information Technology Unit, CDRI, Lucknow
For Suggestions/Observations, Please mail to Suman K Mallik

DSpace Software Copyright © 2002-2005 MIT and Hewlett-Packard - Feedback